Furthermore, a new drug formulation may accelerate the speed of action, improve convenience first sentry bank dosing or obtain decreased food interaction with absorption. The MeltDose technology has allowed us to bring each of our product candidates from program initiation to first firts dose (clinical studies) in less than 12 months.
The typical development period from program initiation to regulatory submission for reformulated drugs is 3-5 years, while conventionally developed drugs typically require between 10 and 12 years before they can be submitted for regulatory approval. LifeCycle Pharma is focusing its efforts on six clinical drug candidates:.
To attain this goal, we are creating value-added formulations of several approved and marketed drugs in a number of important therapeutic areas. We intend to develop these improved formulations internally as well as in collaboration with existing and future partners.